XML 39 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Note S - Revision of Previously Issued Consolidated Financial Statements
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Error Correction [Text Block]

NOTE SREVISION OF PREVIOUSLY ISSUED CONSOLDATED FINANCIAL STATEMENTS

 

Due to errors discovered in the Company’s 2020 and 2021 tax provisions, the Company revised certain previously issued disclosures related to the components of its deferred tax assets and liabilities and valuation allowance as of December 31, 2021 and 2020. Additionally, the Company has revised the reconciliation of its income tax rate computed using the federal statutory rate for the year ended December 31, 2021. The errors related primarily to the calculation of available net operating loss carryforwards and to stock based compensation. Since the Company provided a full valuation allowance on its net deferred tax assets, there was no impact to the Consolidated Balance Sheet as of December 31, 2021 and the consolidated statements of operations, stockholders’ equity and cash flows as of and for the year ended December 31, 2021.

 

 

The Company further reviewed its disclosure of the rate reconciliation and deferred tax calculation along with the valuation allowance of its net deferred tax assets. Other items that were corrected in the disclosure included allowance for doubtful accounts, equipment and leasehold improvements and operating lease liability along with the associated operating lease ROU assets.

 

The below table summarizes the revisions to the reconciliation of our income tax rate computed using the federal statutory rate to our actual income tax rate for the year ended December 31, 2021:

 

   

December 31,

 
   

2021

As Reported

    Adjustments    

2021

As Revised

 
                         

U.S. statutory income tax rate

    21.0

%

    - %     21.0 %

State taxes, net of federal benefit

    -       1.1       1.1  

Permanent differences

    -       (1.0

)

    (1.0

)

Expiration of net operating loss and research credit carryforwards

    -       (13.8

)

    (13.8

)

Expiration and forfeiture of stock options

    -       (1.5

)

    (1.5

)

Other

    -       (2.4

)

    (2.4

)

Valuation allowance     -       (3.4 )     (3.4 )

Effect of net operating loss

    (21.0 )%     21.0       -  

Total

    -

%

    -

%

    -

%

 

The table below summarizes the revisions to the attributes of the deferred tax assets and liabilities as of December 31, 2021 (in thousands):

 

   

December 31,

 
   

2021

As Reported

   

Adjustments

   

2021

As Revised

 
                         

Accrued compensation

  $ 135,000     $ (25,000 )   $ 110,000  

Allowance for doubtful accounts

    75,000       (5,000

)

    70,000  

Stock based compensation

    1,149,000       (663,000

)

    486,000  

Equipment and leasehold improvements

    (10,000

)

    11,000       1,000  

Intangible assets

    75,000       (14,000 )     61,000  

Operating lease liability

    -       59,000       59,000  

Reserve on debt security

    -       13,000       13,000  

Operating lease right-of -use assets

    -       (57,000

)

    (57,000 )

Net operating loss and research credit carryforwards

    14,467,000       681,000       15,148,000  

Valuation allowance

    (15,891,000

)

    -       (15,891,000

)

Net deferred tax assets

  $ -     $ -     $ -  

 

The table below summarizes the revisions to the attributes of the deferred tax assets and liabilities as of December 31, 2020 (in thousands):

 

   

December 31,

 
   

2020

As Reported

   

Adjustments

   

2020

As Revised

 
                         
Accrued compensation   $ 81,000     $ (15,000 )   $ 66,000  

Allowance for doubtful accounts

    474,000       (471,000

)

    3,000  

Stock based compensation

    1,073,000       (511,000

)

    562,000  

Equipment and leasehold improvements

    (14,000

)

    19,000       5,000  

Intangible assets

    65,000       (12,000 )     53,000  

Operating lease liability

    -       111,000       111,000  
Operating lease right-of -use assets     -       (109,000

)

    (109,000 )

Net operating loss and research credit carryforwards

    13,337,000       1,688,000       15,025,000  

Valuation allowance

    (15,016,000

)

    (700,000

)

    (15,716,000

)

Net deferred tax assets

  $ -     $ -     $ -